Acrospire Investment Management LLC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 36 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2017$3,000
-80.0%
700
-85.7%
0.00%
-66.7%
Q4 2016$15,0004,9000.01%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders